Q Synthesis LLC
  • Home
  • Systems Thinking
  • Implementation Science
  • About
  • Contact
  • Publications
  • Updates

HER2 Testing in Breast Cancer: Improving IHC Performance

2/17/2022

 
This virtual tumor board from ASCP will help you understand the latest evidence regarding HER2-low breast cancer, HER2 testing guidelines, the implications for the pathology team as HER2-low therapies emerge, and ways to streamline communications with oncologists and other members of the cancer care team.
Claim CME/CMLE credit at https://store.ascp.org/productlisting/productdetail?productId=143510393

Funded by independent educational grants from AstraZeneca Pharmaceuticals and Daiichi Sankyo, Inc.

Comments are closed.

    Author

    @DrJosephKim
    Joseph Kim, MD, MPH, MBA, FACEHP is the Founder and President of Q Synthesis LLC.

    ​View Dr. Kim's bio on LinkedIn. 

    ​


    Sign up to receive updates:
Q Synthesis LLC
www.qsynthesis.com
  • Home
  • Systems Thinking
  • Implementation Science
  • About
  • Contact
  • Publications
  • Updates